| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |